Hydrogen Sulfide in Biochemistry and Medicine

被引:338
作者
Lee Predmore, Benjamin [2 ]
Joseph Lefer, David [2 ]
Gojon, Gabriel [1 ]
机构
[1] NANT, Monterrey 64320, NL, Mexico
[2] Emory Univ, Sch Med, Dept Surg Cardiothorac Surg, Atlanta, GA USA
基金
美国国家卫生研究院;
关键词
PROSTATE-CANCER CELLS; ISCHEMIA-REPERFUSION INJURY; CYSTATHIONINE BETA-SYNTHASE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DIALLYL TRISULFIDE SUPPRESSES; SODIUM 2-PROPENYL THIOSULFATE; N-TERMINAL KINASE; S-PROPYL CYSTEINE; FACTOR-KAPPA-B; OXIDATIVE-STRESS;
D O I
10.1089/ars.2012.4612
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Significance: An abundance of experimental evidence suggests that hydrogen sulfide (H2S) plays a prominent role in physiology and pathophysiology. Many targets exist for H2S therapy. The molecular targets of H2S include proteins, enzymes, transcription factors, and membrane ion channels. Recent Advances: Novel H2S precursors are being synthesized and discovered that are capable of releasing H2S in a slow and sustained manner. This presents a novel and advantageous approach to H2S therapy for treatment of chronic conditions associated with a decline in endogenous H2S, such as diabetes and cardiovascular disease. Critical Issues: While H2S is cytoprotective at physiological concentrations, it is not universally cytoprotective, as it appears to have pro-apoptotic actions in cancer cells and is well known to be toxic at supraphysiological concentrations. Many of the pleiotropic effects of H2S on health are associated with the inhibition of inflammation and upregulation of prosurvival pathways. The powerful anti-inflammatory, cytoprotective, immunomodulating, and trophic effects of H2S on the vast majority of normal cells seem to be mediated mainly by its actions as an extremely versatile direct and indirect antioxidant and free radical scavenger. While the overall effects of H2S on transformed (i.e., malignant) cells can be characterized as pro-oxidant and pro-apoptotic, they contrast sharply with the cytoprotective effects on most normal cells. Future Directions: H2S has become a molecule of great interest, and several slow-releasing H2S prodrugs are currently under development. We believe that additional agents regulating H2S bioavailability will be developed during the next 10 years. Antioxid. Redox Signal. 17, 119-140.
引用
收藏
页码:119 / 140
页数:22
相关论文
共 251 条
[1]  
Afanasev I. B., 2005, OXIDATION ANTIOXIDAN
[2]   Inflammation and cancer: how friendly is the relationship for cancer patients? [J].
Aggarwal, Bharat B. ;
Gehlot, Prashasnika .
CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (04) :351-369
[3]   Downregulation of the renal and hepatic hydrogen sulfide (H2S)-producing enzymes and capacity in chronic kidney disease [J].
Aminzadeh, Mohammad A. ;
Vaziri, Nosratola D. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (02) :498-504
[4]   The effects of focal ischemia and reperfusion on the glutathione content of mitochondria from rat brain subregions [J].
Anderson, MF ;
Sims, NR .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (03) :541-549
[5]   c-Jun NH2-terminal kinase signaling axis regulates diallyl trisulfide-induced generation of reactive oxygen species and cell cycle arrest in human prostate cancer cells [J].
Antosiewicz, Jedrzej ;
Herman-Antosiewicz, Anna ;
Marynowski, Stanley W. ;
Singh, Shivendra V. .
CANCER RESEARCH, 2006, 66 (10) :5379-5386
[6]  
Aslami H, 2010, NETH J MED, V68, P190
[7]   Hydrogen sulfide induces direct radical-associated DNA damage [J].
Attene-Ramos, Matias S. ;
Wagner, Elizabeth D. ;
Gaskins, H. Rex ;
Plewa, Michael J. .
MOLECULAR CANCER RESEARCH, 2007, 5 (05) :455-459
[8]   Evidence that hydrogen sulfide is a genotoxic agent [J].
Attene-Ramos, MS ;
Wagner, ED ;
Plewa, MJ ;
Gaskins, HR .
MOLECULAR CANCER RESEARCH, 2006, 4 (01) :9-14
[9]   Glutathione dysregulation and the etiology and progression of human diseases [J].
Ballatori, Nazzareno ;
Krance, Suzanne M. ;
Notenboom, Sylvia ;
Shi, Shujie ;
Tieu, Kim ;
Hammond, Christine L. .
BIOLOGICAL CHEMISTRY, 2009, 390 (03) :191-214
[10]   Novel Dithiolethione-Modified Nonsteroidal Anti-Inflammatory Drugs in Human Hepatoma HepG2 and Colon LS180 Cells [J].
Bass, Sara E. ;
Sienkiewicz, Pawel ;
MacDonald, Christopher J. ;
Cheng, Robert Y. S. ;
Sparatore, Anna ;
Del Soldato, Piero ;
Roberts, David D. ;
Moody, Terry W. ;
Wink, David A. ;
Yeh, Grace Chao .
CLINICAL CANCER RESEARCH, 2009, 15 (06) :1964-1972